Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective, Observational Survey Study to Assess the Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine

NCT04600388 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT04600388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04600388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective, Observational Survey Study to Assess the Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine
Lead sponsor
Theranica
Phase
Observational
Overall status
Completed
Start date
September 9, 2020
Completion date
November 10, 2020
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menstrual migraine